Brought to you by:
Walk for PAD awareness this September
Registration for the Society for Vascular Surgery (SVS) Foundation’s 2024 Vascular Health Step Challenge is now open. The Foundation is hosting the third annual Step Challenge throughout the month of September in honor of Peripheral Arterial Disease (PAD) Awareness Month.…
Young vascular surgeons on the PAD frontier: ‘This is the time to seize the day,’ 2024 Veith Lecturer declares
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in the U.S., said Michael Conte, MD, as he gave the second annual Frank J. Veith Distinguished…
Chickasaw Nation study exemplifies how diversity can boost patient access to specialized vascular care
A “feasible and reproducible” intervention bundle characterized by surveys, provider education and patient screening has demonstrated the potential to not only identify gaps in peripheral arterial disease (PAD) primary care practices, but also to help address them. This was a…
Toe and flow session aims to break down barriers to multidisciplinary limb salvage teams
“If you had cancer you would go to a cancer center where you would get a multidisciplinary approach,” SVS President Joseph L. Mills, MD, tells VS@VAM, drawing on this example to highlight the importance of multidisciplinary teams working for amputation…
VAM 2024: Enhancing clinical practice and patient interaction in CLTI
A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded by a grant from the Council of Medical Specialty Societies (CMSS) awarded to the SVS, the…
SVS launches registration for 3rd annual CPVI Skills Course
The Society for Vascular Surgery (SVS) has officially launched registration for the annual Complex Peripheral Vascular Initiatives (CPVI) Skills Course. The first course launched in 2022 after being put on hold in 2020 and 2021 due to the COVID-19 pandemic.…
AVS receives IDE approval from FDA for pivotal intravascular lithotripsy study
Amplitude Vascular Systems (AVS) announced today that it has received an investigational device exemption (IDE) from the Food and Drug Administration (FDA) to begin its pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. The POWER-PAD-II clinical study will evaluate the…
From the editor: House of Cards
On Jan. 22, 2024, the American Heart Association (AHA) and the American College of Cardiology (ACC), together with three other major cardiology societies, submitted a proposal for the formation of the American Board of Cardiovascular Medicine. Essentially, the 157-page document…
The role of deep venous arterialization comes under scrutiny
“Every so often in vascular disease, disruptive technologies come along and the question really is, ‘Is this going to make a big impact on patient care?’” These were the words of CX Executive Board member Robert Hinchliffe, MBChB, clinical professor…
PAD guideline update from ACC, AHA and others centers multispecialty care
New multisociety clinical practice guidelines for the management of lower extremity peripheral arterial disease (PAD) have been published online in the Journal of the American College of Cardiology (JACC). One of the document’s key takeaway messages is that care for…